doi:10.1038/nature08636
Initially, some patients received coverage for these medications, but fewer and fewer patients are getting coverage for them as time goes on
Pick up the body of the prefilled syringe with 1 hand
GLP-1 receptor agonists produce substantial and sustained reductions in food intake clinical trials show average body weight reductions of 1322% depending on the drug, driven by smaller portions, reduced appetite for high-fat and ultra-processed foods, and a shift toward more frequent but smaller eating occasions
He thinks the reason so many cells and neurons are making GLP-1 receptors must be because they want to respond to it. Visuals, taste, smell, memory, and other cues work together to reinforce food-seeking behavior
Subjective cognitive improvements on tirzepatide are secondary to metabolic correction, not evidence that tirzepatide is functioning as an ADHD medication